Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
Leerink Partners
Leerink Partners LLC is an American independent investment bank providing healthcare companies and investors with financial services including M&A advisory, equity and debt capital markets, proprietary research, and sales and trading capabilities. The firm was founded in 1995 by Jeffrey A. Leerink, and is headquartered in Boston, Massachusetts, with U.S. offices in New York City; San Francisco, California; Charlotte, Miami, Los Angeles, Chicago and Nashville.
Leerink Partners was founded in 1995 as Leerink Swann LLC. The following year, the bank established MEDACorp expert network as a joint venture with Dr. Dan Dubin. It acted as a strategic knowledge resource at Leerink, using validation of new products and commercial viability in the assessment of company financials, and corporate due diligence in the medial field as part of a merger and acquisition advisory or capital raising.
In 1999, Inc. named the bank as one of America's 500 fastest growing private companies.
In 2009, the firm expanded its investment banking footprint when 25 senior healthcare bankers joined the firm from Merrill Lynch.
The U.S. Securities and Exchange Commission (SEC) investigated a 2009 merger between Cougar Biotech and Johnson & Johnson in which Leerink advised Cougar.
In 2012, the SEC charged a former Leerink analyst for insider trading. The analyst had obtained confidential information about a merger transaction Leerink was working on and passed this information on to a friend to place trades on his behalf. The analyst gained around $600,000 from this investment and was later sentenced for insider trading.
In 2014, Leerink Swann was rebranded as Leerink Partners LLC and over the next few years established a specialty pharmaceuticals and services franchise (2015), a convertible capital markets business (2016), and established alternative equities and ATM businesses (2019).
In 2016, the firm co-founded the healthcare VC firm Transformation Capital and established Leerink Transformation Fund, a health IT growth equity fund, in 2017.
Hub AI
Leerink Partners AI simulator
(@Leerink Partners_simulator)
Leerink Partners
Leerink Partners LLC is an American independent investment bank providing healthcare companies and investors with financial services including M&A advisory, equity and debt capital markets, proprietary research, and sales and trading capabilities. The firm was founded in 1995 by Jeffrey A. Leerink, and is headquartered in Boston, Massachusetts, with U.S. offices in New York City; San Francisco, California; Charlotte, Miami, Los Angeles, Chicago and Nashville.
Leerink Partners was founded in 1995 as Leerink Swann LLC. The following year, the bank established MEDACorp expert network as a joint venture with Dr. Dan Dubin. It acted as a strategic knowledge resource at Leerink, using validation of new products and commercial viability in the assessment of company financials, and corporate due diligence in the medial field as part of a merger and acquisition advisory or capital raising.
In 1999, Inc. named the bank as one of America's 500 fastest growing private companies.
In 2009, the firm expanded its investment banking footprint when 25 senior healthcare bankers joined the firm from Merrill Lynch.
The U.S. Securities and Exchange Commission (SEC) investigated a 2009 merger between Cougar Biotech and Johnson & Johnson in which Leerink advised Cougar.
In 2012, the SEC charged a former Leerink analyst for insider trading. The analyst had obtained confidential information about a merger transaction Leerink was working on and passed this information on to a friend to place trades on his behalf. The analyst gained around $600,000 from this investment and was later sentenced for insider trading.
In 2014, Leerink Swann was rebranded as Leerink Partners LLC and over the next few years established a specialty pharmaceuticals and services franchise (2015), a convertible capital markets business (2016), and established alternative equities and ATM businesses (2019).
In 2016, the firm co-founded the healthcare VC firm Transformation Capital and established Leerink Transformation Fund, a health IT growth equity fund, in 2017.